Page last updated: 2024-11-03

riluzole and HIV Infections

riluzole has been researched along with HIV Infections in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research Excerpts

ExcerptRelevanceReference
"Riluzole is able to increase (effective dose from 1 to 1000 nM) the cell-survival of T cells from HIV-1-infected patients and inhibit spontaneous apoptosis."1.35Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole. ( Achour, A; Biquard, JM; M'Bika, JP, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achour, A1
M'Bika, JP1
Biquard, JM1
Cachia, D1
Izzy, S1
Ionete, C1
Salameh, J1

Other Studies

2 other studies available for riluzole and HIV Infections

ArticleYear
Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole.
    Virology, 2009, Mar-30, Volume: 386, Issue:1

    Topics: Apoptosis; Cell Survival; HIV Infections; Humans; Immunologic Factors; Interferon Type I; Riluzole;

2009
Brachial amyotrophic diplegia in the setting of complete HIV viral load suppression.
    BMJ case reports, 2012, Dec-06, Volume: 2012

    Topics: Antiretroviral Therapy, Highly Active; Arm; HIV Infections; Humans; Male; Middle Aged; Muscle Weakne

2012